Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th January 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bloomsbury SET announces new grants
"The Bloomsbury SET Impact Connector programme will support innovators as they take promising therapeutics from the laboratory to communities worldwide" - Professor Richard Bomphrey.

The research alliance has announced new grants to fight infectious diseases and AMR.

A research alliance led by the Royal Veterinary College (RVC), The Bloomsbury SET, has announced 12 new grants for projects to fight against infectious disease or antimicrobial resistance (AMR).

The projects, which are supported by over £1 million of funding, will develop tools to deliver new vaccines, diagnostics and therapeutics to benefit both animal and human health. 

Comprised of the RVC, London School of Hygiene and Tropical Medicine (LSHTM), the Infection Innovation Consortium (iiCON) led by the Liverpool School of Tropical Medicine, and SOAS University of London, the consortium targets academics in the early stages of commercialisation. 

Twelve projects have been awarded grants, including a project looking at the probabilistic diagnostic algorithm doe the early serological detection of Johne's Disease (JD) in dairy cattle, led by Professor Javier Guitian. 

Other projects awarded grants include a study led by Dr Nicholas Furnham, which seeks to advance inhibitors targeting Cathepsin D as a new drug treatment for schistosomiasis, and a research project led by iiCON focusing on the commercialisation of the LSTM barrier bed net. 

Dr Emma Tomlinson, Chair of The Bloomsbury SET Steering Committee, and head of Research Development at the RVC, said: “These twelve projects represent the strongest applications received by The Bloomsbury SET from our partner universities, all working with relevant industry partners. 

“In addition to development funding, the Commercialisation Pilot also includes support from a dedicated mentor and networking and training opportunities through The Bloomsbury SET. We look forward to seeing these ideas develop further along their translation journey.”

Interim vice principal for Research at the RVC, Professor Richard Bomphrey, added: “There has never been a better time to bring together an outstanding interdisciplinary and inter-sectorial consortium to take on the globally important and pressing issues of infectious disease and antimicrobial resistance. 

“The Bloomsbury SET Impact Connector programme will support innovators as they take promising therapeutics from the laboratory to communities worldwide.”

 

Image (C) Royal Veterinary College

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.